Clinical Trial Update: Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating HM15275 for Type 2 diabetes mellitus is listed, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HM15275

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Type 2 Diabetes Mellitus, T2DM | Phase 2 | Status: NOT_YET_RECRUITING